Significance of erythopoietin receptor antibody concentration in diabetes
Not Applicable
- Conditions
- diabetes mellitus
- Registration Number
- JPRN-UMIN000014475
- Lead Sponsor
- Yokohama City University Medical Center
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 54
Inclusion Criteria
Not provided
Exclusion Criteria
1)Patients with severe diabetic ketoacidosis or come within recent 6 month 2) Patents with severe infectious disease, peri-operation and severe trauma 3)Patients with pregnancy (possible pregnancy) or nursing. 4)Patients ineligible for some other medical reason by a physician
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Plasma concentration of erythopoietin antobodies
- Secondary Outcome Measures
Name Time Method Factors which may affect plasma concentration of erythopoietin antobodies 1)GAD antibodies 2)Thyrogloblin (Tg) antibodies 3)Peroxidase (Pox) antibodies 4) HbA1c, fasting and post-prandial blood glucose, immnunoreactive insulin (IRI) 5) Age 6) Anemia (Hb, Hct, RBC) 7) eGFR, urinal albumin/ Crea, clinical stage for nephropathy